Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

• Conditions: Epilepsy

• Registration Number: NCT00317668
• Lead Sponsor: Hadassah Medical Organization

Brief Summary

The investigators will check the serum of epilepsy patients for antibodies against glutamate receptors and double stranded DNA. They will characterise the patients (by the kind of epilepsy, autoimmune disease comorbidity, and cognitive profile).

Detailed Description

Not available

Study Timeline

• Status Verified: 2006-04
• Study First Submitted: 2006-04-23
• Study First Submitted QC: 2006-04-23
• Study First Posted: 2006-04-25
• Study Start: 2006-11
• Last Update Submitted: 2007-04-29
• Last Update Posted: 2007-05-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• 120 epilepsy patients from the epilepsy clinic and Emergency Room (ER)
• Controls: 100 patients with other neurological diseases and no epilepsy; and 30 healthy volunteers.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Hadassah Ein-Kerem Medical Center; 🇮🇱 Jerusalem, Israel